Bimatoprost Solution/ Drops
Product Images NDC 62332-507

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bimatoprost (NDC 62332-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bimatoprost-bottle-2-5ml (Bimatoprost Bottle 2 5ml)

Label for Bimatoprost Ophthalmic Solution 0.03% (0.3 mg/mL) in a 2.5 mL bottle. The label states the product is for ophthalmic use only, includes preservative benzalkonium chloride, and is manufactured by Alembic Pharmaceuticals, Inc. in Bedminster, NJ, USA. It features the NDC 62332-507-25 and instructions to store between 2°C to 25°C (36°F to 77°F).*

FDA Label Image

Bimatoprost-bottle-5ml (Bimatoprost Bottle 5ml)

Label for Bimatoprost Ophthalmic Solution 0.03% (0.3 mg/mL) in a 5 mL bottle, manufactured by Alembic Pharmaceuticals Inc. This prescription eye drop solution includes benzalkonium chloride preservative and is sterile, for use in the eyes only. The label displays dosage, storage instructions, and manufacturer information.*

FDA Label Image

Bimatoprost-carton-2-5ml (Bimatoprost Carton 2 5ml)

Packaging label for Bimatoprost Ophthalmic Solution 0.03% by Alembic Pharmaceuticals Inc., a sterile ophthalmic solution for prescription use only. The 2.5 mL bottle contains 0.03% bimatoprost with benzalkonium chloride preservative. The label includes storage instructions, usual dosage directions, manufacturer and labeler information, and a barcode.*

FDA Label Image

Bimatoprost-carton-5ml (Bimatoprost Carton 5ml)

Packaging label for Bimatoprost Ophthalmic Solution 0.03%, sterile solution/drops for ophthalmic use, in a 5 mL container. The label includes usage instructions, storage conditions (2°C to 25°C), and manufacturer information: Alembic Pharmaceuticals Inc., NJ, USA, and Gland Pharma Limited, Hyderabad, India. The solution contains bimatoprost 0.3 mg/mL as the active ingredient, with benzalkonium chloride as preservative and several inactives. The label states the product is Rx only and for use in eyes only.*

FDA Label Image

Bimatoprost-struc (Bimatoprost Struc)

Chemical structure diagram of bimatoprost, showing its molecular arrangement including hydroxyl groups, double bonds, and aromatic ring, as relevant to the active ingredient of the ophthalmic solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.